Pregnancy, Arsenic and Immune Response

CompletedOBSERVATIONAL
Enrollment

784

Participants

Timeline

Start Date

October 14, 2018

Primary Completion Date

January 6, 2020

Study Completion Date

January 6, 2020

Conditions
Arsenic--ToxicologyImmunologic Disorders Complicating PregnancyVaccine Response ImpairedMicronutrient DeficiencyInfluenza
Interventions
BIOLOGICAL

Seasonal influenza vaccine - VAXIGRIP TETRA influenza vaccine (quadrivalent, split virion, inactivated)

Influenza virus (quadrivalent, split virion, inactivated) of the strains that comply with the World Health Organization (WHO) recommendations (Northern Hemisphere) and European Union (EU) decision for the 2018/2019 season. The quadrivalent vaccine is propagated in fertilised hens' eggs from healthy chicken flocks.

Trial Locations (1)

Unknown

JiVitA Maternal and Child Health and Nutrition Research Program, Gaibandha

All Listed Sponsors
collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

collaborator

Institute of Epidemiology, Disease Control and Research

OTHER

collaborator

Johns Hopkins Bangladesh - The JiVitA Project Site

UNKNOWN

collaborator

University of Graz

OTHER

collaborator

Columbia University

OTHER

collaborator

UNC Gillings School of Global Public Health

UNKNOWN

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT03930017 - Pregnancy, Arsenic and Immune Response | Biotech Hunter | Biotech Hunter